NDC11 57237031318
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57237-0313-18 | 57237-0313 |
| 57237-313-18 | 57237-313 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextromethorphan HBr. and Guaifenesin | DEXTROMETHORPHAN HBR. AND GUAIFENESIN | Rising Pharma Holdings, Inc. | e463e60f-d0db-4ee7-9713-ddf25aa38a43 | 2026-09-22 | Warnings | 57237-313-18 57237-313 57237031318 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.